特发性颅内高压 - Suppr

Suppr

超能文献

Idiopathic intracranial hypertension.

作者信息

Sinclair Alex J, Woolley Rebecca, Mollan Susan P

机构信息

Department of Neurotrauma and Neurodegeneration, University of Birmingham, Birmingham, England.

Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, England.

出版信息

JAMA. 2014 Sep 10;312(10):1059-60. doi: 10.1001/jama.2014.8894.

DOI:10.1001/jama.2014.8894

PMID:25203090

Abstract

摘要

相似文献

Idiopathic intracranial hypertension.

JAMA. 2014 Sep 10;312(10):1059-60. doi: 10.1001/jama.2014.8894.

Idiopathic intracranial hypertension--reply.

JAMA. 2014 Sep 10;312(10):1060. doi: 10.1001/jama.2014.8903.

Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial.

JAMA. 2014;311(16):1618-9. doi: 10.1001/jama.2014.3325.

The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait.

J Neuroophthalmol. 2016 Mar;36(1):1-3. doi: 10.1097/WNO.0000000000000347.

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

JAMA. 2014;311(16):1641-51. doi: 10.1001/jama.2014.3312.

Metamorphopsia as an initial complaint of idiopathic intracranial hypertension.

Arch Ophthalmol. 2005 Jul;123(7):1003-6. doi: 10.1001/archopht.123.7.1003.

Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.

J Neuroophthalmol. 2016 Mar;36(1):13-9. doi: 10.1097/WNO.0000000000000322.

Fulminant idiopathic intracranial hypertension managed with oral acetazolamide.

Can J Ophthalmol. 2016 Aug;51(4):e121-e125. doi: 10.1016/j.jcjo.2016.03.014. Epub 2016 Jun 21.

Should Acetazolamide Be the First-Line Treatment for Patients With Idiopathic Intracranial Hypertension?

J Neuroophthalmol. 2017 Jun;37(2):182-186. doi: 10.1097/WNO.0000000000000513.

Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.

J Neuroophthalmol. 2016 Mar;36(1):6-12. doi: 10.1097/WNO.0000000000000327.

引用本文的文献

Glial and neuronal antibodies in patients with idiopathic intracranial hypertension.

Neurol Sci. 2017 Oct;38(10):1817-1822. doi: 10.1007/s10072-017-3066-7. Epub 2017 Jul 21.

Mechanism of action of acetazolamide and idiopathic intracranial hypertension.

Front Neurol. 2015 Feb 3;6:13. doi: 10.3389/fneur.2015.00013. eCollection 2015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Idiopathic intracranial hypertension.

作者信息

Sinclair Alex J, Woolley Rebecca, Mollan Susan P

机构信息

Department of Neurotrauma and Neurodegeneration, University of Birmingham, Birmingham, England.

Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, England.

出版信息

JAMA. 2014 Sep 10;312(10):1059-60. doi: 10.1001/jama.2014.8894.

DOI:10.1001/jama.2014.8894

PMID:25203090

Abstract

摘要

相似文献

Idiopathic intracranial hypertension.

JAMA. 2014 Sep 10;312(10):1059-60. doi: 10.1001/jama.2014.8894.

Idiopathic intracranial hypertension--reply.

JAMA. 2014 Sep 10;312(10):1060. doi: 10.1001/jama.2014.8903.

Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial.

JAMA. 2014;311(16):1618-9. doi: 10.1001/jama.2014.3325.

The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait.

J Neuroophthalmol. 2016 Mar;36(1):1-3. doi: 10.1097/WNO.0000000000000347.

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

JAMA. 2014;311(16):1641-51. doi: 10.1001/jama.2014.3312.

Metamorphopsia as an initial complaint of idiopathic intracranial hypertension.

Arch Ophthalmol. 2005 Jul;123(7):1003-6. doi: 10.1001/archopht.123.7.1003.

Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.

J Neuroophthalmol. 2016 Mar;36(1):13-9. doi: 10.1097/WNO.0000000000000322.

Fulminant idiopathic intracranial hypertension managed with oral acetazolamide.

Can J Ophthalmol. 2016 Aug;51(4):e121-e125. doi: 10.1016/j.jcjo.2016.03.014. Epub 2016 Jun 21.

Should Acetazolamide Be the First-Line Treatment for Patients With Idiopathic Intracranial Hypertension?

J Neuroophthalmol. 2017 Jun;37(2):182-186. doi: 10.1097/WNO.0000000000000513.

Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.

J Neuroophthalmol. 2016 Mar;36(1):6-12. doi: 10.1097/WNO.0000000000000327.

引用本文的文献

Glial and neuronal antibodies in patients with idiopathic intracranial hypertension.

Neurol Sci. 2017 Oct;38(10):1817-1822. doi: 10.1007/s10072-017-3066-7. Epub 2017 Jul 21.

Mechanism of action of acetazolamide and idiopathic intracranial hypertension.

Front Neurol. 2015 Feb 3;6:13. doi: 10.3389/fneur.2015.00013. eCollection 2015.